Results 191 to 200 of about 79,480 (272)

Seromucinous borderline ovarian tumors: Clinical and ultrasound characteristics and association with endometriosis

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 9, Page 1860-1870, September 2026.
Seromucinous borderline ovarian tumors frequently appear as unilateral, left‐sided cysts with ground‐glass echogenicity and moderately vascularized solid components. Their strong association with ipsilateral endometriosis provides crucial sonographic and clinical clues for an accurate preoperative diagnosis.
Simona Del Forno, Marisol Doglioli, Chiara Landolfo, Giovanna Palomba, Claudia Vicenzi, Matilde Antonelli, Lucia De Meis, Francesca Govoni, Roberto Paradisi, Diego Raimondo, Renato Seracchioli   +10 more
wiley   +1 more source

Fertility outcomes and ovarian function recovery after anti‐NMDAR encephalitis: A retrospective cohort study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 9, Page 1823-1832, September 2026.
Acute hypothalamic–pituitary–ovarian axis suppression is common in anti‐NMDAR encephalitis, yet ovarian function and fertility recover favorably even in teratoma‐associated cases, supporting reassuring long‐term reproductive prognoses. Abstract Introduction Anti‐N‐methyl‐D‐aspartate receptor (anti‐NMDAR) encephalitis predominantly affects women of ...
Jia Wang, Jie Ding, Han Cai, YingXiang Wang, HaoTian Wu   +4 more
wiley   +1 more source

Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non‐muscle‐invasive bladder cancer

BJU International, Volume 138, Issue 3, Page 491-500, September 2026.
Objectives To evaluate whether longitudinal tumour‐informed circulating tumour DNA (ctDNA) testing identifies patients at increased risk of upstaging and recurrence in high‐risk non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods A cohort of 52 patients with high‐risk NMIBC underwent serial plasma ctDNA testing using a personalised tumour ...
Can Aydogdu, Betty Wang, Sean Thomas McSweeney, Gabriela Diaz, Taeris Guzman, Sahab Ram Dewala, Rakesh Arya, Mikayla Baer, Amanda Nizam, Christopher Wee, Shalini Moningi, Alberto Pieretti, Christopher J. Weight, Rebecca Campbell, Mohit Sindhani, Jihad Kaouk, Robert Abouassaly, Laura Bukavina   +17 more
wiley   +1 more source

KPNA2 Drives Immunosuppression in Ovarian Cancer via CCL2/CCR2‐Dependent MDSC Recruitment

Cancer Science, Volume 117, Issue 9, Page 2461-2479, September 2026.
KPNA2 drives intratumoral MDSC accumulation and immunosuppression in ovarian cancer via the NF‐κB/CCL2/CCR2 axis. Mechanistically, KPNA2 facilitates NF‐κB/p65 nuclear translocation and induces CCL2 transcription, recruiting MDSCs to establish an immunosuppressive microenvironment.
Qingli Li, Jitong Zhao, Lu Yang, Lin Li, Ce Bian, Tao Yi, Huiqiong Huang, Gang Zheng, Xiaojuan Lin   +8 more
wiley   +1 more source

Cathepsin V (CTSV) Shapes the Epigenetic–Immune Landscape of Bladder Cancer and Emerges as a Noninvasive Biomarker

International Journal of Urology, Volume 33, Issue 9, September 2026.
ABSTRACT Objective The aim of this study was to perform a comprehensive characterization of CTSV regulation in bladder cancer (BC) and its association with clinicopathological features, prognosis, and tumor stroma modulation using multi‐omics databases.
Wallax Augusto Silva Ferreira, Fabio Albuquerque Marchi, Glauco Akelinghton Freire Vitiello, Rolando André Rios Villacis, Ana Paula Drummond Rodrigues, Edivaldo Herculano Correa de Oliveira   +5 more
wiley   +1 more source

Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery

International Journal of Urology, Volume 33, Issue 9, September 2026.
ABSTRACT Purpose To evaluate whether a simplified mutation‐based classification using archival formalin‐fixed paraffin‐embedded (FFPE) specimens provides prognostic information beyond pathological stage in patients with upper tract urothelial carcinoma (UTUC) undergoing nephroureterectomy.
Kazuki Yanagida, Ichiro Takada, Tsuyoshi Ishida, Kazuki Takei, Kenjiro Kishitani, Hideyuki Minagawa, Taketo Kawai, Tomoyuki Kaneko, Yuko Sasajima, Tohru Nakagawa   +9 more
wiley   +1 more source

Beyond staging: toward a layered risk architecture after radical cystectomy for bladder cancer. [PDF]

Transl Androl Urol
Gilfrich C, Kravchuk A, Rinderknecht E, Haas M, Burger M, Wolff I, Brookman-May SD, May M.   +7 more
europepmc   +1 more source

Neoadjuvant chemotherapy prior to radical cystectomy for muscle‐invasive bladder cancer with variant histology

Cancer, 2017
M. Vetterlein, S. Wankowicz, T. Seisen, Richard D. Lander, B. Löppenberg, F. Chun, M. Menon, Maxine Sun, J. Barletta, T. Choueiri, J. Bellmunt, Q. Trinh, M. Preston   +12 more
semanticscholar   +1 more source

Long-Term Outcomes and Paired Immune and Genomic Exploratory Analyses After Neoadjuvant Dose-Dense MVAC in Muscle-Invasive Bladder Cancer: A Single-Centre Case Series. [PDF]

Cancers (Basel)
De Maeseneer D, Decruyenaere A, Van der Meulen J, Loontiens S, Rosseel T, Volders PJ, Verbeke S, Fonteyne V, Van Praet C, Berquin C, Rottey S.   +10 more
europepmc   +1 more source

Tranexamic acid in radical cystectomy: a systematic review and meta-analysis. [PDF]

Surg Pract Sci
Fereidooni F, Dehbozorgi M, Khalilzadeh Bonab D, Shafiee A, Mirhosseini F, Goodarzi S.   +5 more
europepmc   +1 more source